Jyong Biotech (MENS) Payables (2024 - 2025)
Jyong Biotech's Payables was $7.71 million in the quarter ended Dec 31, 2025, up 6.7% from $7.23 million a year earlier.
Powered by 
Analysis
Jyong Biotech (MENS) Payables (2024 - 2025) Analysis & Trends
- In earlier years, Payables was $7.23 million in the year ended Dec 31, 2024 and -$2,000 in the year ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Jyong Biotech | 132.29 Mn | 131.11 Mn | - | 7.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.71 Mn |
| Jun 30, 2025 | 22.44 Mn |
| Dec 31, 2024 | 7.23 Mn |
API Access
Jyong Biotech Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=MENS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "MENS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=MENS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();